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Fish aquaculture is the world's fastest growing food production industry and infectious diseases are a 23 
major limiting factor. Vaccination is the most appro iate method for controlling infectious diseases 24 
and a key reason for the success of salmonid cultivation and has reduced the use of antibiotics. The 25 
development of fish vaccines requires the use of a gre t number of experimental animals that are 26 
challenged with virulent pathogens. In vitro cell culture systems have the potential to replace in vivo 27 
pathogen exposure for initial screening and testing of novel vaccine candidates/preparations, and for 28 
batch potency and safety tests. PBL contain major immune cells that enable the detection of both 29 
innate and adaptive immune responses in vitro. Fish PBL can be easily prepared using a hypotonic 30 
method and is the only way to obtain large numbers of immune cells non-lethally. Distinct gene 31 
expression profiles of innate and adaptive immunity have been observed between bacterins prepared 32 
from different bacterial species, as well as from different strains or culturing conditions of the same 33 
bacterial species. Distinct immune pathways are activated by pathogens or vaccines in vivo that can be 34 
detected in PBL in vitro. Immune gene expression in PBL after stimulation with vaccine candidates 35 
may shed light on the immune pathways involved that le d to vaccine-mediated protection. This study 36 
suggests that PBL are a suitable platform for initial screening of vaccine candidates, for evaluation of 37 
vaccine-induced immune responses, and a cheap alternative for potency testing to reduce animal use 38 
in aquaculture vaccine development.   39 
 40 
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1.  Introduction 47 
 48 
Fish aquaculture is the world's fastest growing industry within the animal food production sector. 49 
However, infectious diseases not only cost up to 20% of production value but also have a significant 50 
impact on individual fish health and welfare, and the environment [1-3]. Vaccination is the most 51 
appropriate method for controlling disease problems, both from a production and welfare point of 52 
view [4-6]. Vaccination plays an important role in large-scale commercial fish farming. It has been a 53 
key reason for the success of salmonid cultivation and has reduced the use of antibiotics [7-9]. Almost 54 
100% of Atlantic salmon are vaccinated with multivalent vaccines prior to sea transfer in Norway, the 55 
largest producer of farmed salmon in the world [10]. 56 
 57 
Inactivated whole-cell bacterins constitute the main bacterial vaccines used in aquaculture. The first 58 
commercially licensed vaccine for fish (in 1976) was  formalin-killed bacterin delivered by 59 
immersion against Yersinia ruckeri, the causative agent of enteric redmouth disease (ERM) in 60 
salmonids [11-12]. Following the success of this product, vaccines for vibriosis were developed. 61 
Whilst these vaccines are able to induce protective immunity by bath/dip vaccination, bacterin 62 
immersion vaccines against Aeromonas salmonicida (the causative agent of furunculosis) were not 63 
effective in the field, so oil adjuvant-based bacterin vaccines were developed despite some side effects 64 
[7-8, 13]. Iron-regulated outer membrane proteins (IROMPs) of A. salmonicida induced under iron-65 
restricted growth conditions were found important protective antigens [14]. Anti-IROMPs antibodies 66 
are bactericidal to virulent A. salmonicida strains in vitro and specific anti-IROMP antibody responses 67 
correlate strongly with protection against furunculosis [15]. Thus, bacterins prepared from A. 68 
salmonicida grown under iron-deprived conditions are also good vaccine candidates and led to the 69 
non-adjuvanted vaccine against furunculosis AquaVac FNM Plus (Intervet UK Ltd) 70 
(http://www.vmd.defra.gov.uk/productinformationdatabase/SPC_Documents/SPC_122154.DOC) that 71 
uses both pathogenic and non-pathogenic strains of A. salmonicida, i.e. strain MT423 and strain 72 
MT004. 73 
 74 
Whilst commercial vaccines are available for many of the major bacterial diseases and a few viral 75 
diseases of aquaculture, no commercial vaccines have been produced against fish parasitic infections 76 
[4-6] and more vaccines to emerging diseases are waiting to be developed. Furthermore, disease 77 
outbreaks do occur on fish farms from time to time ev n after vaccination with effective commercial 78 
vaccines, e.g. the ERM vaccine prepared from motile Y. ruckeri lost its efficacy against non-motile 79 
strains [16-17]. In Denmark, although the majority of rainbow trout are vaccinated using commercial 80 




ruckeri and Vibrio anguillarum, disease outbreaks requiring treatment with antibiotics still occur [18]. 82 
These examples highlight the need for continuous improvement of vaccines for long-term protection 83 
in aquaculture. The development of fish vaccines requi s thorough efficacy and safety testing before 84 
they can be marketed. All batches of vaccines must be tested for potency and safety before use. These 85 
tests are currently reliant upon mortality testing where fish are exposed to virulent pathogens and 86 
relative percent survival is measured, which requires the use of a great number of experimental 87 
animals [19-21]. Although a clear-cut approach, it does not unveil the underlying molecular 88 
mechanisms of vaccination-mediated protection and is cost- and time-consuming [19-21]. With an 89 
increasing focus on the 3 R's (Replacement, Reduction and Refinement), in vitro systems using fish 90 
immune cells have the potential to replace in vivo pathogen exposure for initial screening and testing 91 
of novel vaccine candidates/preparations, and for batch potency and safety tests.  92 
  93 
Fish immune cells can be isolated from major immune organs (e.g. head kidney and spleen), mucosal 94 
tissues (e.g. intestine and gills), as well as blood [22-25]. Blood is the only source of leucocytes that 95 
can be obtained easily in a non-lethal way and that allows multiple sampling of the same fish to 96 
investigate vaccine-mediated immune responses over time. Peripheral blood mononuclear cells 97 
(PBMC) have been extensively used in mammalian vaccine development, to evaluate vaccine efficacy 98 
and for safety testing [26]. We recently optimised a rapid hypotonic peripheral blood leucocyte (PBL) 99 
isolation method in salmonids. As with PBMC isolated by gradient centrifugation, PBL isolated by 100 
this hypotonic method contain the major immune cell types needed to monitor adaptive immune 101 
responses, such as T cells, B cells, monocytes/macrophages and neutrophils [25]. The PBL prepared 102 
can proliferate, phagocytose and respond to stimulation with PAMPs and cytokines [25, 27].  103 
 104 
The current study aimed to investigate if the expression of immune genes could be differentially 105 
modulated in PBL by a variety of bacterin vaccine candidates. The bacterins were prepared from the 106 
pathogenic A. salmonicida MT423 grown in iron-replete and iron-depleted media, the non-pathogenic 107 
MT004, and a formalin inactivated Y. ruckeri model vaccine as well. We found that immune genes ar  108 
differentially modulated in a bacterin- and time-dependent manner. These results are discussed in the 109 
context of immune mechanisms of vaccine mediated protection and potential use as surrogate 110 
biomarkers of vaccine efficacy and safety.  111 





2. Materials and methods  114 
 115 
2.1. Bacterin preparation 116 
The A. salmonicida subsp. salmonicida non-pathogenic strain MT004, and pathogenic strain MT423, 117 
and the pathogenic Y. ruckeri strain MT3072 used in this study were obtained from the Marine 118 
Scotland Science Marine Laboratory, Aberdeen, UK, as described previously [28-29]. The bacteria 119 
were inoculated into tryptic soya broth (TSB, Sigma) at 22 ℃ for 18-24 h in a shaking incubator at 120 
100 rpm. The MT423 strain was cultured in normal TSB or in TSB supplemented with 100 µm 2,2′-121 
bipyridyl (Sigma, UK) to deplete iron (Fe-) to induce IROMPs expression [14]. After culture, the 122 
bacteria were inactivated by addition of formalin solution (Sigma, UK) to the culture media to 1%. 123 
The bacteria were then incubated overnight on a slow magnetic stirrer at room temperature. Bacteria 124 
were collected by centrifugation and washed three times using phosphate buffered saline (PBS, 125 
pH7.4, Sigma, UK). The bacteria were weighed, resuspended in PBS at 10 mg/ml and stored at – 80 126 
℃ ready for use. The bacterins prepared were plated onto TSA plates and incubated for 48 h at 22°C, 127 
with no bacterial growth confirming complete inactiva ion of the bacteria. 128 
2.2 PBL preparation and stimulation 129 
Rainbow trout (Oncorhynchus mykiss) purchased from the Mill of Elrich Trout Fishery 130 
(Aberdeenshire, Scotland, UK) were maintained at 14±1°C in a freshwater recirculation aquarium [27, 131 
30]. The PBL from four fish were prepared as described previously [25]. Briefly, blood was drawn 132 
from the caudal vein using a BD Vacutainer containing l thium heparin (BD, UK). The red blood cells 133 
were lysed by combining 4 ml blood and 36 ml ice-cold cell culture grade water (GE Healthcare Life 134 
Sciences, UK) for 20 s. Then 4 ml cooled 10x PBS (Sigma, UK) was added to revert the medium to 135 
isotonicity. The suspension was left in ice for 5–10 min and filtrated through a 70 µm cell strainer 136 
(Greiner Bio One, UK), pelleted by centrifugation (200 g, 5 min), and washed once with incomplete 137 
cell culture medium (Leibovitz medium L-15, Life Technologies, UK) supplemented with 100 IU/ml 138 
penicillin, 100 µg/ml streptomycin (P/S), and 1% foetal calf serum (FCS, Sigma, UK). The PBL were 139 
counted using a Neubauer chamber and 0.5% trypan blue, resuspended in complete cell culture 140 
medium (as above except 10% FCS) and distributed in 12-well cell culture plates at 2×106 cells/ml, 2 141 
ml/well. The PBL from each fish were then stimulated with 100 µg/ml of inactivated bacterin (1) A. 142 
salmonicida MT423 (MT423), (2) A. salmonicida MT423 grown in iron-depleted medium (MT423 143 
Fe-), (3) A. salmonicida MT004 (MT004), (4) an equal combination of MT423 (Fe-) & MT004, (5) Y. 144 
ruckeri MT3072 and PBS as control. The cells were incubated  20°C for 4 h, 8 h, 24 h and 72 h, 145 
harvested in 1.5 ml TRI reagent (Sigma, UK), and stored at −80 °C until RNA extraction.  146 




Total RNA extraction, cDNA synthesis and real-time PCR (qPCR) analysis of gene expression were 148 
carried out as described by Wang et al. [27,31]. The RI lysates were thawed at room temperature and 149 
total RNA was prepared as per the manufacturer’s instructions. The RNA was reverse transcribed to 150 
cDNA using RevertAid Reverse Transcriptase (Thermo Scientific). The resultant cDNAs were diluted 151 
in TE buffer (10mM Tris-HCl, 1mM EDTA, pH 8.0) (Sigma) ready for use. The qPCR was 152 
performed in duplicate using a LightCycler 480 (Roche) system and 2× SYBR green Master Mix 153 
made with an Immolase DNA Polymerase kit (Bioline). The genes studied included those encoding 154 
the known cytokines, chemokines and chemokine receptors, suppressor of cytokine signalling (SOCS) 155 
proteins, acute phase proteins (APPs), antimicrobial peptides (AMPs), cellular markers, and master 156 
transcription factors of T cell responses. The prime  sets were designed with at least one primer across 157 
an intron, tested to ensure that PCR products could nly be amplified from cDNA samples and not 158 
from genomic DNA, and are detailed in Supplementary Table S1. The data were analysed using the 159 
LightCycler 480 integrated software. The gene expression level for each sample was normalised to 160 
that of the housekeeping gene, elongation factor (EF)-1α, and expressed as an arbitrary unit (AU) 161 
where 1 AU = the average expression in the control cells at 4 h. A fold change for each treatment was 162 
also calculated as the average expression divided by that of time matched controls. 163 
 164 
2.4 Data visualization, clustering and statistical analysis 165 
The fold changes of gene expression were analysed using ClustVis [32] for visualisation of a heatmap 166 
and for Principal Component Analysis (PCA). The arbitrary units of each gene were scaled and log2 167 
transformed to improve the normality of real-time quantitative PCR measurements before statistical 168 
analysis as described previously [31]. A paired-samples T test was used to determine the level of 169 
difference between the treatments at each time point usi g the IBM SPSS Statistics package 25.0 170 
(SPSS Inc., Chicago, Illinois), with differences considered significant at p < 0.05. The Spearman’s rho 171 
correlation analysis of gene expression was performed on selected pro-/anti-inflammatory cytokines, 172 
adaptive cytokines, IL-12 family and chemokine receptors. The four time points from each bacterin 173 
stimulation was combined for this analysis (n=16).  174 
 175 
 176 




3. Results and discussion  178 
 179 
In this study, freshly prepared PBL were stimulated for 4 h, 8 h, 24 h and 72 h with five Gram-180 
negative bacterin preparations. Bacterin A was from Y. ruckeri that is an effective vaccine against 181 
ERM [12]. Bacterins B (MT004) and C (MT423) were from non-pathogenic and pathogenic A. 182 
salmonicida subsp. salmonicida strains, respectively, but neither are effective vaccines against 183 
furunculosis [13-14]. Bacterin E was from MT423 cultured under iron-depleted condition that 184 
represent an effective vaccine candidate [14] and bacterin D was an equal mix of bacterins C and E 185 
that represents a vaccine previously used in the field. The expression of 93 immune relevant genes 186 
(Table S1) was examined by RT-qPCR and the expression normalised to EF-1α. The expression of 18 187 
genes (IL-17A/F1b, IL-17A/F2a, IL-17A/F2b, IL-17A/F3, IL-17D, IL-23P19, IL-27P28B, IL-188 
12P35B, IL-20, SOCS2A, SOCS2B, SOCS3A, SOCS3B, β-defensin 1-3, CC4La and CCR6B, Table 189 
S1) was low or undetectable in control samples at 4 h, and thus were excluded from further analysis. 190 
The remaining 75 genes were expressed and modulated in PBL. The relative expression levels across 191 
different time points (with statistical analysis) are presented in Figs. S1-14 and the average fold 192 
change at each time point presented in Table S2. 193 
 194 
3.1. Clustering and principal component analysis 195 
In response to bacterin stimulation PBL gene expression changed over time from 4 h to 72 h. 196 
Hierarchical clustering analysis of the fold changes across four time points revealed time-dependent 197 
gene expression patterns (Fig. 1).  Three major clusters of genes were apparent. Cluster 1 contained 198 
several chemokine receptor genes (CCR6A, CCR7A, CCR7B, CCR9A, CCR9B, CCR4Lc2 and 199 
CXCR3B) that were induced/higher at 4 h and 72 h but low at 8 h and 24 h as compared to the 200 
unstimulated samples. Cluster 2, mainly consisted of adaptive cytokines, that were gradually induced 201 
and peaked at 8 h or 24 h, and remained elevated to 72 h. Cluster 3 genes, including mainly pro- and 202 
anti-inflammatory cytokines and APPs, were induced early, peaked at 4 h or 8 h, and returned to 203 
resting levels by 24 h to 72 h (Fig. 1). The clustering patterns of the different bacterin preparations 204 
changed over time but with Y. ruckeri always clustering away from the various A. salmonicida 205 
bacterins at all four time points, suggesting a major effect of bacterial species, as well as different 206 
preparations of the same species/strain, on immune ge expression. 207 
 208 
PCA analysis of the fold change of 75 genes at the 4 time points revealed that the first two 209 
components accounted for 85% of the variation (Fig. 2). The biplot indicates that the bacterin 210 
modulated gene expression can be divided into four distinct groups based on time, in agreement with 211 
the major effects of stimulation time on gene expression seen in Fig. 1.   Different bacterin 212 




effects of bacterin preparation were well separated from each other, suggesting this gives the most 214 
discriminating power. Thus, the bacterin modulated g ne expression was analysed further with a focus 215 
at 4 h. 216 
 217 
3.2. Modulation of the expression of pro- and anti-inflammatory genes by bacterins 218 
Genes involved in the inflammatory response are modulated in vivo by vaccination in salmonid 219 
lymphoid organs such as head kidney [33] and spleen [30]. Therefore, we examined first in PBL the 220 
expression of proinflammatory cytokines (IL-1β [34], TNFα [35], IL-6, IL-11 [36], M17 [37] and IL-221 
34 [38]), chemokines (IL-8 and CXCL11_L1 [39]), anti-i flammatory cytokines (IL-10 [40], TGF-β1 222 
[41] and nIL-1Fm [42]), and negative regulators of cytokine signalling (SOCS) [43].  The expression 223 
of all these genes could be modulated in PBL by bacterin stimulation (Figs. S1-3). The expression of 224 
the majority of the genes was rapidly induced at 4 h and peaked at 4 h or 8 h, and this modulation 225 
subsided by 24 h or 72 h (Table S2). The exception was the down-regulation of TNFα2 and TGFβ1A, 226 
that are highly expressed in PBL (as seen by the small ∆CP, Table S1). A noticeable difference of 227 
gene expression change was the rapid and strong induct on of gene expression by A. salmonicida 228 
preparations, compared to a gradual but lasting increase induced by the Y. ruckeri bacterin (e.g. IL-229 
1β1, TNFα3, IL-8, Figs. S1-2). Major differences between different paralogues in response to bacterin 230 
stimulation were also observed, in terms of magnitude of the response (e.g. IL-1β paralogues), 231 
response kinetics (e.g. IL-10 paralogues), and types of response seen (e.g. down-regulation of TNFα2 232 
but up-regulation of other TNFα paralogues) (Figs. S1, S3). Differential responses of cytokine 233 
paralogues have been observed previously [30, 34-35, 40-41] and may indicate neo- or sub-234 
functionalisation. 235 
 236 
At 4 h post stimulation, the expression of IL-1β1-2, TNFα3, IL-6, IL-8 and IL-10A showed a similar 237 
pattern, where the highest induction was seen with MT423, followed by MT423(Fe-), MT423 (Fe-) + 238 
MT004, MT004, and the lowest (but significant) induction seen with Y. ruckeri (Fig. 3). This 239 
expression pattern, to a lesser extent, was also oberved with IL-1β3, TNFα1, IL-11, M17 and nIL-1F. 240 
Interestingly, Y. ruckeri tended to induce higher levels of the anti-inflammatory gene TGFβ1B and 241 
SOCS1A than MT423(Fe-) + MT004 at 4h. These results indicate a stronger inflammatory response 242 
induced by A. salmonicida strains compared to Y. ruckeri, and that the expression of a set of immune 243 
genes can distinguish the responses induced in PBL by different bacterin preparations.  244 
 245 
3.3. Modulation of the expression of genes of adaptive immunity by bacterins. 246 
The expression of signature cytokines for Th1 (IFNγ1-2 [44]), Th2 (IL-4/13A, IL-4/13B1-2, [45]) and 247 
Th17 (IL-17A/F1a, [46]) type responses was next studied. Th1 cytokines were induced at 4 h by A. 248 
salmonicida preparations but not by Y. ruckeri. However, Th17 and Th2 cytokines (IL-4/13B1-2) 249 




followed the pattern of Th1 cytokines. The expression of other cytokines (IL-2A, IL-4/13A, IL-17C2, 251 
IL-18, IL-21 and IL-22 [48]) was less responsive. In general, A. salmonicida preparations induced a 252 
relatively early (at 4 h and/or 8 h) adaptive cytokine expression, and Y. ruckeri induced a late (at 8 h 253 
or later) cytokine response (Fig. S4-6). 254 
 255 
The expression of master transcription factors for Th1 (T-bet), Th2 (GATA3 [49]), Th17 (RORγ 256 
[50]), and regulatory T cells (FoxP3A/B [51]) was also examined. At 4 h, T-bet expression was 257 
upregulated by MT004 and Y. ruckeri, and RORγ expression by Y. ruckeri only. A small but 258 
significant increase of FoxP3A/B was observed in all stimulated samples, but GATA3 was refractory 259 
at 4 h (Fig. 4). The effects of bacterin stimulation were small at other time points (Fig. S6). The 260 
effects of bacterin-stimulation on T cell markers (CD3ε, CD4, CD28 and CTLA4) and B cell markers 261 
were also small (Figs. S7-8), with a minor increase in the expression of CD3ε and CD4 at 4 h by all 262 
bacterins (Fig. 4). The large increases of proinflammatory cytokine gene expression and minor 263 
changes on adaptive genes at 4 h suggest a rapid PAMP-activated response by bacterins that may 264 
trigger later adaptive responses. 265 
 266 
3.4. Modulation of the expression of the IL-12 family by bacterins. 267 
The expression of subunits of the IL-12 family followed the pattern of the major pro- and anti-268 
inflammatory cytokines, with a rapid induction of the α-subunit of IL-12 (P35A1 and P35A2 [52-53]) 269 
and IL-27 (P28A, [54]), and the β-subunits of IL-12 (P40B1 and P40B2, [52-53]) at early time points 270 
(4 h and 8 h, Fig. S9). The exception was P40C where the induced expression peaked at 8 h or 24 h. 271 
At 4 h, MT423 was a strong stimulator of IL-12 family expression compared to Y. ruckeri, as seen 272 
with the major inflammatory and Th1 cytokines (Fig. 5). The differential expression of different 273 
subunits suggests that different isoforms of IL-12 can be induced by different vaccine candidates, 274 
which have the potential to modulate differential Th cell development after vaccination. 275 
 276 
3.5. Modulation of the expression of chemokine receptors by bacterins. 277 
The expression of chemokine receptor CXCR3A [55] was low but highly induced by bacterin 278 
stimulation in PBL, and followed the pattern of themajor inflammatory and Th1 cytokines (Fig. S10). 279 
The changes of expression of other chemokine receptors were small and showed a decrease in 280 
expression at late time points (24 h and 48 h) for several receptors, e.g. CXCR2, CXCR3B, CXCR4A, 281 
CXCR4B, CCR9A and CCR9B (Figs. S10-11), perhaps due to a decrease of the receptor expressing 282 
cells during in vitro culture [27]. A small transient induction at 4 h was seen with the majority of 283 
chemokine receptors except CXCR4A (Fig. S10-12). The expression of CXCR2, CXCR4B, XCR3, 284 
CCR6A and CCR4Lc1 was induced by all the bacterin peparations with similar levels. However, Y. 285 




CCR4Lc2 and CCRL1 [56], compared to MT423 at 4 h (Fig. 6). In contrast A. salmonicida 287 
preparations induced a higher level of CXCR3A and CCBP2 [57] transcripts than Y. ruckeri (Fig. 6). 288 
 289 
Chemokine receptors are present on all leucocytes and their expression can be differentially 290 
modulated to position the right immune cells in the right place [58]. The adaptive immune response is 291 
initiated in the secondary lymphoid organs with the arrival of antigen or mature dendritic cells (DCs). 292 
The antigen-loaded DCs and naive T cells must be co-localized to allow the rare antigen-specific 293 
naive T cells to scan and interact with the DCs. The co-localization of immune cells is promoted by 294 
chemokine receptor-mediated migration [58-59]. Of note, mammalian CXCR3, CCR4 and CCR6 are 295 
important for Th1, Th2 and Th17 type adaptive immunity, respectively; CCR7 regulates the migration 296 
of DCs, B cells and T cells; and CCR9 regulates GALT development and homing of T cells to gut 297 
[58]. The differential ability of vaccine candidates to modulate early chemokine receptor expression 298 
may provide novel insights into the immune pathways ctivated by vaccination. Interestingly, the Y. 299 
ruckeri bacterin that is an effective vaccine induces a stronger expression of CXCR3B, CCR4Lc2, 300 
CCR7, and CCR9, compared to the other vaccine candid tes studied. This information could be a 301 
starting point to further dissect the immune pathways ctivated by vaccination that provide protection.   302 
 303 
3.6. Modulation of the expression of APP and AMP genes by bacterins. 304 
Lastly, the expression of several APP and AMP genes that are known to be induced in vivo 305 
by vaccination and bacterial infection was studied [30, 33]. COX2 expression was rapidly 306 
induced at 4 h and followed the expression pattern of the other inflammatory genes (Fig. 307 
S13). The induced expression of SAA, SAP1, CATH1, CATH2 and LEAP1/hepcidin was 308 
relatively low at 4 h, peaking at 8 h or 24 h (Figs. S13-14). Such expression kinetics are in 309 
line with the in vivo observation that early induction of proinflammatory cytokines by 310 
vaccines and PAMPs induces APPs and AMPs [30, 60]. Bacterin stimulation had only minor 311 
effects on the expression of SAP2 and β- efensin 4. At 4 h, MT423 was more potent at 312 
induction of SAA, SAP1, COX-2 and CATH1 than Y. ruckeri (Fig. 7). 313 
 314 
3.7. PBL immune gene expression mimics the in vivo response to vaccination 315 
The expression of major pro- and anti-inflammatory genes (IL-1, IL-6, IL-8, TNFα, IL-10 etc.), acute 316 
phase protein genes (SAA, SAP1 and COX-2), antimicrob al peptide genes (CATH1, CATH2 and 317 
LEAP1), as well as adaptive cytokine genes (IFNγ, IL-17A/F and IL-4/13) are increased in PBL by 318 
bacterin vaccine candidates in this study. Their expr ssion is also increased in vivo by injection 319 
vaccination in rainbow trout [18, 30, 61], Atlantic salmon [33, 62] and other fish species [63-65]. 320 




contribute to the increased gene expression observed. However, Y. ruckeri bacterin modulated gene 322 
expression in rainbow trout PBL is similar to the spleen response to injected unadjuvanted vaccine 323 
[30], suggesting that in vitro PBL immune gene expression does indeed largely mimic the immune 324 
response to vaccination i  vivo.  325 
 326 
Despite the similarity, a direct analogy or generalisation of the PBL immune response to vaccine 327 
candidates in vitro to the response in vivo should be cautious. The in vivo vaccine responses are 328 
usually studied in internal organs, such as spleen, h ad kidney or liver that are away from the primary 329 
injection/vaccination site. The response in these int rnal organs depends on the degree of immune 330 
activation at the vaccination site, the trafficking of immune cells (especially antigen presenting cells) 331 
between tissues and the vaccination site, and the cellular composition of each organ. Consequently, 332 
immune gene expression in response to vaccination can be different in different tissues [29, 30, 65], 333 
and can even show fish species-specificity [66]. For example, genes associated with T and B 334 
lymphocyte activity and migration, such as CCR7 andCCR9, are decreased in peritoneal cells after 335 
intraperitoneal injection vaccination [63]. This decr ased gene expression may be a consequence of 336 
different phenomena, that include a rapid influx of myeloid cells to the peritoneal cavity after 337 
vaccination [67], or exit of leucocytes expressing hi h levels of CCR7 and CCR9 that home to 338 
secondary lymphoid tissues to initiate adaptive immune responses, or the actions of both.   339 
 340 
3.8. Correlation analysis of gene expression 341 
To further exploit the differential power of immune g ne expression in PBL after bacterin stimulation, 342 
the Spearman rank ordered correlation analysis was performed on selected genes that showed large 343 
responses. A good positive correlation was observed within groups of pro-/anti-inflammatory 344 
cytokines (IL-1β, IL-6, IL-8, TNFα3 and IL-10), adaptive cytokines (IFNγ1-2, IL-4/13B1-2, IL-345 
17A/F1a and IL-22), IL-12 family cytokines (IL-12 P35A1 and P40B2, and IL-27P28A) and 346 
chemokine receptor genes (CXCR3A, CCR7B and CCR9A) after stimulation with each bacterin 347 
preparation as detailed in Tables S3-7. However, the correlations between different groups were 348 
complex and largely stimulation-dependent. For example, in ERM stimulated samples, the expression 349 
of IL-1β1 (and to a large extent IL-8 and IL-10A) was found to be positively correlated with the 350 
expression of T cell growth factor (IL-2B), Th1 (IFNγ1-2), Th2 (IL-4/13B1-2), Th22 (IL-22), and IL-351 
12 (P35A1 and P40B2) family cytokines, but negatively correlated to chemokine receptors (CCR7B 352 
and CCR9A), and there was no correlation with Th17 (IL-17A/F1a) and Treg (TGFβ1A-B) cytokines 353 
(Table 1). These correlations were lost in most cases when stimulated with A. salmonicida bacterins. 354 
Notably, positive correlations were found between pro-/anti-inflammatory cytokines (IL-1β1, IL-6, 355 
IL-8, TNFα3 and IL-10A) and Treg cytokines, and chemokine receptors after A. salmonicida bacterin 356 





A coordinated activation of proinflammatory genes and daptive cytokines with a negative-correlation 359 
to chemokine receptor expression may retain immune cells at the injection site after efficacious ERM 360 
vaccination. Although the interpretation of the correlations will be context dependent and needs 361 
further investigation, these complex correlations of gene expression further demonstrate the power of 362 
PBL gene expression to distinguish differential responses to stimulation with vaccine candidates. 363 
 364 
3.9. The value of PBL responses for vaccine candidate screening and vaccine potency testing 365 
In contrast to vaccine-induced immune responses in vivo, that occur in immune organs usually after 366 
immune cell trafficking, the PBL immune cell composition is relatively constant and the response to 367 
vaccine components is direct. This may allow analysis of subtle changes in gene expression in 368 
response to vaccine antigens to be detectable in PBL. For instance, a small but significant rapid 369 
induction of chemokine receptor expression (e.g. CCR7 and CCR9) was observed in PBL after 370 
bacterin stimulation in this study, that may be undetectable or even decreased as seen in peritoneal 371 
cells in vivo after vaccination [53]. Unlike cell lines that consist of a pure cell population, PBL 372 
prepared by the hypotonic method [25] contain multiple immune cells seen i  vivo, that allow both 373 
innate and adaptive immune responses to be analysed. PBL are the only leucocytes in fish that can be 374 
prepared non-lethally, allowing the same fish to be sampled multiple times.  The distinct gene 375 
expression profiles of innate and adaptive immunity i  PBL after bacterin stimulation observed in this 376 
study suggest that PBL are a suitable platform for initial screening of vaccine candidates and for 377 
evaluation of vaccine-induced immune responses. The PBL system may also be used to evaluate some 378 
adjuvant responses (e.g. PAMPs and cytokines) which could be simply added to the cells with the 379 
antigens.  380 
 381 
Although a bacterin dose-dependent response was not perf rmed in this study, a trend to intermediate 382 
gene expression of many genes in MT423 (Fe-) + MT004 stimulated cells, compared to MT423 (Fe-) 383 
and MT004 used individually, was apparent (Figs. 3-7). These three groups contain the same total 384 
amount of bacteria but the first group has half each of the last two, suggesting a sensitive dose-385 
response effect on PBL gene expression. As seen in mammals [68], vaccine-mediated protection in 386 
fish is also vaccine dose-dependent [10, 69]. When t  correlates of vaccine dose-response profiles of 387 
PBL gene expression and in vivo protection have been established, PBL will potentially be a cheap 388 
alternative for potency tests to reduce animal use [12].  389 
 390 
PBL may also be used to investigate immunological memory, which is a feature of adaptive immune 391 
responses to vaccination. Immunological memory is the ability of the immune system to respond more 392 
rapidly and effectively to pathogens due to the exist nce of antigen-specific memory T/B cells. The 393 
PBL isolated from vaccinated fish should contain memory T cells and B cells that are expected to 394 




antigens. However, due to the complexity of PBL andthe rarity of memory cells, pre-isolation of T/B 396 
cells, and homogenous dendritic cells/antigen presenting cells for presenting antigens may have to be 397 
applied.   398 
 399 
3.10. PBL immune gene expression may help shed light on the protective mechanisms induced 400 
by vaccination  401 
Distinct immune gene expression profiles in PBL have been induced in this study by bacterin 402 
preparations including those reflecting effective vaccines, such as Y. ruckeri and MT423 (Fe-), and 403 
non-effective bacterin candidates. Bacterial species have major effects on PBL gene expression with 404 
bacterin preparations from A. salmonicida behaving in a more similar way in comparison to Y. ruckeri. 405 
A. salmonicida preparations induce a rapid upregulation of proinflammatory genes whilst the kinetics 406 
of inflammatory gene expression was slower and peaked later with Y. ruckeri. These effects have also 407 
been observed in vivo with live bacterial infection. For example, the expression of IL-1β, TNFα and 408 
IL-10 peaked at 6-12 h after A. salmonicida infection in Atlantic salmon [70], whilst in Y. ruckeri 409 
infected rainbow trout the peak occurred after 1-3 days [29, 71]. Although a direct comparison 410 
between the two pathogens in terms of dose, kinetics and immune genes examined in the same fish 411 
species is lacking, the current PBL response and in vivo data in salmonids suggest that distinct 412 
immune pathways are activated by each pathogen in vivo that can be mimicked in vitro by bacterin 413 
stimulation of PBL.  414 
 415 
It is interesting to note that whilst the Y. ruckeri bacterin is an effective vaccine it induces a weak and 416 
relatively slow induction of proinflammatory genes in PBL. In addition, the bacterin from A. 417 
salmonicida grown under iron-depleted conditions has a lower capa ity to induce pro- and anti-418 
inflammatory gene expression at 4 h than the MT423 bacterin but also represents an effective vaccine 419 
candidate. This suggests that inflammatory potential doesn’t correlate to protective efficacy of a 420 
vaccine candidate. The Y. ruckeri bacterin induces an early expression of master transc iption factors 421 
for Th1, Th2 and Th17 (T-bet, GATA3 and RORγ) cells as well as chemokine receptors (CXCR3B, 422 
CCR6, CCR7, CCR9 and CCR4Lc2) at 4 h, suggesting the activation of Th1, Th2 and Th17 type 423 
adaptive responses that may be essential for this vaccine mediated immunity. Both MT423 (Fe-) and 424 
Y. ruckeri bacterins induce higher levels of CCR4Lc2 and CCR6A at 72 h, with their mammalian 425 
orthologues important for Th2 and Th17 type adaptive immunity [58]. A Th2 and Th17 biased 426 
response was observed in Atlantic salmon vaccinated with an oil-adjuvanted A. salmonicida bacterin 427 
[72]. The induction of a Th2 type response is in agreement with the fact that antibody titre correlates 428 
with vaccine-mediated protection against infection with A. salmonicida [10] and Y. ruckeri [69]. Thus, 429 
immune gene expression in PBL after stimulation with vaccine candidates may shed light on the 430 





3.11. Conclusions 433 
PBL can be easily prepared non-lethally and contain major immune cells that enable the detection of 434 
both innate and adaptive immune responses. Distinct gene expression profiles of innate and adaptive 435 
immunity have been observed between bacterins prepared from different bacterial species, as well as 436 
from different strains or culturing conditions of the same bacterial species. Hence immune pathways 437 
activated by pathogens or vaccines in vivo can also be detected in PBL in vitro. Immune gene 438 
expression in PBL after stimulation with vaccine candidates may shed light on the immune pathways 439 
involved in vaccine-mediated protection in fish. Taken as a whole, this study suggests that PBL are a 440 
suitable platform for initial screening of vaccine candidates, for evaluation of vaccine-induced 441 
immune responses, and represent a cheap alternative for potency testing to reduce animal use in 442 
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6. Figure legend 666 
 667 
Fig. 1. Hierarchical clustering analysis of immune gene expression modulated by bacterins in 668 
PBL. Freshly prepared PBL from four trout were stimulated with formalin inactivated bacterins of Y. 669 
ruckeri (A), A. salmonicida subsp. salmonicida strains MT004 (B) and MT423 (C), MT423 cultured 670 
under iron-depleted condition (MT423 (Fe-)) (E), and an equal mixture of MT004 and MT423 (Fe-) 671 
(D) for 4 h, 8 h, 24 h and 72 h. The fold change data set from 75 genes (Table S2) was inputted to the 672 
CluctVis program for clustering analysis. Three clusters of gene expression patterns, C1, C2 and C3, 673 
are apparent.   674 
 675 
Fig. 2. Principal component analysis of immune gene expression modulated by bacterins in 676 
PBL. Freshly prepared PBL from four trout were stimulated with formalin inactivated bacterins of Y. 677 
ruckeri (A), A. salmonicida subsp. salmonicida strains MT004 (B) and MT423 (C), MT423 cultured 678 
under iron-depleted condition (MT423 (Fe-)) (E), and an equal mixture of MT004 and MT423 (Fe-) 679 
(D) for 4 h, 8 h, 24 h and 72 h. The fold change data set from 75 genes (Table S2) was inputted to the 680 
CluctVis program for principal component analysis.  681 
 682 
Fig. 3. Modulation of PBL expression of pro- and anti-inflammatory genes by bacterins. 683 
Rainbow trout PBL were stimulated with bacterins of Y. ruckeri, A. salmonicida strains 684 
MT423 and MT004, MT423 grown under iron-depleted conditions (Fe-), and a mixture of 685 
MT423 (Fe-) and MT004 for 4 h, 8 h, 24 h and 72 h. T e average (+SEM, N=4) gene 686 
expression was quantified by RT-qPCR. The expression level of each sample was normalised 687 
with that of EF-1α, and expressed as arbitrary units where one unit equals the average 688 
expression level in the control samples at 4 h. The fold change of expression at 4 h is shown 689 
with the full range of times studied in Figs. S1-3. Different letters over the bars indicate 690 
significant differences (p<0.05, paired samples T test).  691 
 692 
Fig. 4. Modulation of PBL expression of cytokines and markers of adaptive immunity 693 
by bacterins. Rainbow trout PBL were stimulated with bacterins ad gene expression was 694 
quantified as described in Fig. 3. The fold change of gene expression at 4 h is shown with the 695 
full range of times studied in Figs. S4-7. Different letters over the bars indicate significant 696 





Fig. 5. Modulation of PBL expression of IL-12 cytokine family by bacterins. Rainbow 699 
trout PBL were stimulated with bacterins and gene expr ssion was quantified as described in 700 
Fig. 3. The fold change of gene expression at 4 h is shown with the full range of times 701 
studied in Fig. S9. Different letters over the bars indicate significant differences (p<0.05, 702 
paired samples T test).  703 
 704 
Fig. 6. Modulation of PBL expression of chemokine receptor genes by bacterins. 705 
Rainbow trout PBL were stimulated with bacterins and gene expression was quantified as 706 
described in Fig. 3. The fold change of gene expression at 4 h is shown with the full range of 707 
times studied in Figs. S10-12. Different letters over the bars indicate significant differences 708 
(p<0.05, paired samples T test).  709 
 710 
Fig. 7. Modulation of PBL expression of acute phase protein and antimicrobial peptide 711 
genes by bacterins. Rainbow trout PBL were stimulated with bacterins ad gene expression 712 
was quantified as described in Fig. 3. The fold change of gene expression at 4 h is shown 713 
with the full range of times studied in Figs. S13-14. Different letters over the bars indicate 714 
significant differences (p<0.05, paired samples T test).  715 
 716 
 717 
Table 1 Spearman’s rho correlation coefficient (R) and the 2-tailed significance (* = p < 0.05, ** = p < 0.01) between expression levels of selected pro-/anti-inflammatory 
cytokines and adaptive cytokines, IL-12 family and chemokine receptors in PBL stimulated with ERM, MT423 (Fe-), MT004, MT423 (Fe-)+MT004 and MT423 as described 



































































































ERM  .648** .924** .799** .625** .864** .873** .799** .620* .667** .680** .304 .589* .218 -.156 .848** .234 .883** -.365 -.776** -.792** 
MT423 (Fe-)  .982** .641** -.015 .890** .921** .152 .477 .433 .082 .121 .109 .447 .432 .632** .976** .974** .391 .876** .653** .715** 
MT004  .974** .762** .262 .715** .735** .675** .168 .171 -.076 .038 .065 .212 .088 .526* .947** .782** .690** .589* .135 .109 
MT423(Fe-)+MT004  .962** .809** .100 .915** .767** .376 .297 .168 -.026 .021 .306 .235 .609* .509* .947** .962** .518* .741** .240 .482 
MT423  .918** .647** -0.259 .938** .798** -.371 .185 .368 -.391 -.338 .096 .226 .633** .571* .950** .947** .432 .876** .774** .824** 
IL-6 
ERM .648**  .385 .235 .188 .632** .321 .135 -.003 .068 .047 -.308 .077 .499* -.447 .694** .653** .432 -.182 -.386 -.379 
MT423 (Fe-) .982**  .621* -.035 .887** .941** .075 .452 .419 .072 .129 .112 .429 .476 .597* .982** .962** .406 .856** .632** .712** 
MT004 .974**  .724** .235 .679** .788** .661** .135 .156 -.109 .038 .079 .188 .062 .515* .953** .776** .674** .620* .132 .126 
MT423(Fe-)+MT004 .962**  .706** .047 .900** .702** .318 .184 .085 -.118 -.024 .188 .132 .647** .336 .944** .976** .459 .697** .208 .468 
                      
MT423 .918**  .438 -.174 .847** .758** -.218 .185 .259 -.488 -.359 -.066 .029 .481 .541* .953** .885** .424 .829** .768** .765** 
IL-8 
ERM .924** .385  .921** .656** .738** .962** .906** .768** .835** .859** .480 .764** .160 -.018 .762** -.035 .953** -.412 -.808** -.812** 
MT423 (Fe-) .641** .621*  .700** .571* .541* .539* .908** .790** .648** .729** .646** .726** -.038 .826** .594* .547* .885** .447 .229 .097 
MT004 .762** .724**  .671** .429 .829** .868** .674** .617* .379 .424 .450 .691** -.206 .647** .744** .429 .915** .165 -.332 -.362 
MT423(Fe-)+MT004 .809** .706**  .547* .662** .790** .650** .620* .521* .382 .491 .535* .571* .209 .668** .788** .703** .826** .441 -.090 .100 
MT423 .647** .438  .112 .691** .327 -.266 .279 .403 .226 .162 .549* .609* .745** .644** .556* .662** .468 .538* .350 .512* 
CXCL11_L1 
ERM .799** .235 .921**  .515* .668** .944** .868** .771** .771** .812** .514* .784** .146 -.129 .700** -.124 .891** -.515* -.815** -.806** 
MT423 (Fe-) -.015 -.035 .700**  -.025 -.124 .508* .681** .637** .796** .862** .558* .550* -.538* .503* -.021 -.100 .856** -.168 -.279 -.494 
MT004 .262 .235 .671**  -.200 .582* .746** .838** .805** .768** .876** .821** .815** -.441 .344 .206 -.250 .745** -.487 -.703** -.726** 
MT423(Fe-)+MT004 .100 .047 .547*  -.015 .322 .585* .681** .724** .679** .826** .553* .582* -.374 .458 .159 -.009 .794** -.174 -.496 -.412 
MT423 -.259 -.174 .112  -.315 -.255 .609* .659** .497 .738** .897** .400 .438 -.316 .474 -.144 -.297 .550* -.432 -.447 -.553* 
TNFα3 
ERM .625** .188 .656** .515*  0.476 .568* .553* .315 .382 .429 .360 .258 .166 .182 .506* .153 .618* .112 -.434 -.441 
MT423 (Fe-) .890** .887** .571* -.025  .827** -.172 .543* .608* .175 .130 .151 .537* .618* .686** .893** .936** .380 .918** .779** .806** 
MT004 .715** .679** .429 -.200  .209 .166 -.079 -.106 -.188 -.282 -.318 -.079 .532* .582* .721** .944** .389 .877** .615* .615* 
MT423(Fe-)+MT004 .915** .900** .662** -.015  .545* .062 .322 .191 .009 -.053 .268 .209 .782** .511* .821** .912** .485 .874** .464 .712** 
MT423 .938** .847** .691** -.315  .726** -.536* .197 .368 -.300 -.306 .218 .297 .824** .547* .871** .929** .435 .906** .821** .894** 
IL-10A 
ERM .864** .632** .738** .668** 0.476  .768** .638** .494 .512* .503* .178 .403 .149 -.326 .765** .194 .753** -.379 -.730** -.759** 
MT423 (Fe-) .921** .941** .541* -.124 .827**  .025 .383 .359 .029 .094 .050 .356 .482 .585* .897** .915** .303 .838** .671** .715** 
MT004 .735** .788** .829** .582* .209  .858** .529* .501* .150 .329 .465 .541* -.347 .379 .753** .344 .730** .116 -.452 -.423 
MT423(Fe-)+MT004 .767** .702** .790** .322 .545*  .561* .323 .275 .050 .213 .312 .316 .018 .547* .796** .727** .475 .372 -.194 .035 
MT423 .798** .758** .327 -.255 .726**  -.281 .365 .512* -.330 -.275 .167 .266 .338 .543* .768** .759** .506* .756** .755** .681** 
 
Figure 1 
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1. PBL contain major immune cells to allow the detection of innate and adaptive immune 
responses.  
2. Distinct immune gene expression profiles are activated in PBL by bacterin vaccine candidates. 
3. A rapid 4 h stimulation gives the most discriminating power of the effects of bacterin 
preparations.  
4. Immune gene expression in PBL may shed light on the mechanisms of vaccine-mediated 
protection.  
5. PBL are a suitable in vitro platform to reduce animal use in aquaculture vaccine development.   
 
Resource Source Identifier 
Antibody 
anti-inflammatory   
Chemical 
2,2'- bipyridyl   
EDTA   
FCS   
Fe-   
formalin   
iron   
lithium   
penicillin   
phosphate buffered saline   
streptomycin   
Tris-HCl   
trypan blue   
ProteinPeptide 
Polymerase   
proteins   
Reverse Transcriptase   
 
